Valeant Pharmaceuticals Announces Second Quarter Results Conference Call Date And Details
LAVAL, Quebec, July 15, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to host a conference call and live webcast on August 9, 2016 to discuss second quarter 2016 financial results.
Conference Call Details:
|
Date |
Tuesday, August 9, 2016 |
|
Time |
8:00 a.m. ET |
|
Webcast |
|
|
Participant Event Dial-in |
(877) 876-8393 (North America) |
|
(973) 200-3961 (International) | |
|
Participant Passcode |
48835456 |
|
Replay Dial-in |
(855) 859-2056 (North America) |
|
(404) 537-3406 (International) | |
|
Replay Passcode |
48835456 (Replay available until August 17, 2016) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:Laurie W. Little [email protected] orElif McDonald[email protected]514-856-3855 877-281-6642 (toll free)
Media:Renée SotoorChris Kittredge/Jared LevySard Verbinnen & Co.212-687-8080
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-second-quarter-results-conference-call-date-and-details-300299291.html
SOURCE Valeant Pharmaceuticals International, Inc.